Neurotrophic factors in bipolar disorders patients with manic episode

Abstract

Background/aim: Neurotrophins are one of the most important molecule groups affecting cerebral neuroplasticity. The amount ofevidence about the role of changes in neuroplasticity in the pathophysiology of bipolar disease is growing.Materials and methods: We measured serum levels of brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF),neurotrophin-3 (NT-3), glial cell-line derived neurotrophic factor (GDNF), vascular endothelial growth factor (VEGF), insulin-likegrowth factor-1 (IGF-1), fibroblast growth factor (FGF)-2, neuritin 1 (Nrn 1) in bipolar 1 manic episode patients (n = 45) and healthycontrol group.Results: When controlled for age, BMI and cortisol, it was found that the serum levels of BDNF, NGF, NT-3, VEGF and FGF-2 ofbipolar manic episode patients were not statistically different compared to those of the control group. GDNF level and Nrn 1 levelswere significantly lower (P = 0.003 and P = 0.025 respectively) while IGF-1 levels were significantly higher than the control group (P= 0.0001). ROC analysis was performed and the area under the the curve was calculated as 0.737, 0.766 for GDNF, IGF-1 respectively.Conclusion: The changes in the levels of GDNF, IGF-1 and Nrn 1 might be involved in pathopysiology of bipolar disorder, and GDNF,IGF-1 may be considered as state markers in bipolar manic episode.